154 related articles for article (PubMed ID: 33262201)
21. Clinical Next-Generation Sequencing for Precision Oncology in Rare Cancers.
Groisberg R; Hong DS; Roszik J; Janku F; Tsimberidou AM; Javle M; Meric-Bernstam F; Subbiah V
Mol Cancer Ther; 2018 Jul; 17(7):1595-1601. PubMed ID: 29654067
[TBL] [Abstract][Full Text] [Related]
22. Epidemiology of rare cancers and inequalities in oncologic outcomes.
Gatta G; Trama A; Capocaccia R;
Eur J Surg Oncol; 2019 Jan; 45(1):3-11. PubMed ID: 29032924
[TBL] [Abstract][Full Text] [Related]
23. Targetable Alterations in Adult Patients With Soft-Tissue Sarcomas: Insights for Personalized Therapy.
Lucchesi C; Khalifa E; Laizet Y; Soubeyran I; Mathoulin-Pelissier S; Chomienne C; Italiano A
JAMA Oncol; 2018 Oct; 4(10):1398-1404. PubMed ID: 29801054
[TBL] [Abstract][Full Text] [Related]
24. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
25. Genomic profiling of BCOR-rearranged uterine sarcomas reveals novel gene fusion partners, frequent CDK4 amplification and CDKN2A loss.
Lin DI; Hemmerich A; Edgerly C; Duncan D; Severson EA; Huang RSP; Ramkissoon SH; Connor YD; Shea M; Hecht JL; Ali SM; Vergilio JA; Ross JS; Elvin JA
Gynecol Oncol; 2020 May; 157(2):357-366. PubMed ID: 32156473
[TBL] [Abstract][Full Text] [Related]
26. Comprehensive molecular profiling broadens treatment options for breast cancer patients.
Kawaji H; Kubo M; Yamashita N; Yamamoto H; Kai M; Kajihara A; Yamada M; Kurata K; Kaneshiro K; Harada Y; Hayashi S; Shimazaki A; Mori H; Akiyoshi S; Oki E; Oda Y; Baba E; Mori M; Nakamura M
Cancer Med; 2021 Jan; 10(2):529-539. PubMed ID: 33274848
[TBL] [Abstract][Full Text] [Related]
27. Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet-a population-based study.
Gatta G; Capocaccia R; Botta L; Mallone S; De Angelis R; Ardanaz E; Comber H; Dimitrova N; Leinonen MK; Siesling S; van der Zwan JM; Van Eycken L; Visser O; Žakelj MP; Anderson LA; Bella F; Kaire I; Otter R; Stiller CA; Trama A;
Lancet Oncol; 2017 Aug; 18(8):1022-1039. PubMed ID: 28687376
[TBL] [Abstract][Full Text] [Related]
28. Comprehensive genomic profiling of head and neck squamous cell carcinoma reveals FGFR1 amplifications and tumour genomic alterations burden as prognostic biomarkers of survival.
Dubot C; Bernard V; Sablin MP; Vacher S; Chemlali W; Schnitzler A; Pierron G; Ait Rais K; Bessoltane N; Jeannot E; Klijanienko J; Mariani O; Jouffroy T; Calugaru V; Hoffmann C; Lesnik M; Badois N; Berger F; Le Tourneau C; Kamal M; Bieche I
Eur J Cancer; 2018 Mar; 91():47-55. PubMed ID: 29331751
[TBL] [Abstract][Full Text] [Related]
29. Molecular profiling of soft-tissue sarcomas with FoundationOne
Scheipl S; Brcic I; Moser T; Fischerauer S; Riedl J; Bergovec M; Smolle M; Posch F; Gerger A; Pichler M; Stoeger H; Leithner A; Heitzer E; Liegl-Atzwanger B; Szkandera J
Ther Adv Med Oncol; 2021; 13():17588359211029125. PubMed ID: 34367342
[TBL] [Abstract][Full Text] [Related]
30. Thymoma and thymic carcinoma in children and adolescents: a report from the European Cooperative Study Group for Pediatric Rare Tumors (EXPeRT).
Stachowicz-Stencel T; Orbach D; Brecht I; Schneider D; Bien E; Synakiewicz A; Rod J; Ferrari A; Cecchetto G; Bisogno G
Eur J Cancer; 2015 Nov; 51(16):2444-52. PubMed ID: 26259494
[TBL] [Abstract][Full Text] [Related]
31. Integration of genomic copy number variations and chemotherapy-response biomarkers in pediatric sarcoma.
Cheng L; Pandya PH; Liu E; Chandra P; Wang L; Murray ME; Carter J; Ferguson M; Saadatzadeh MR; Bijangi-Visheshsaraei K; Marshall M; Li L; Pollok KE; Renbarger JL
BMC Med Genomics; 2019 Jan; 12(Suppl 1):23. PubMed ID: 30704460
[TBL] [Abstract][Full Text] [Related]
32. Diverse EGFR Exon 20 Insertions and Co-Occurring Molecular Alterations Identified by Comprehensive Genomic Profiling of NSCLC.
Riess JW; Gandara DR; Frampton GM; Madison R; Peled N; Bufill JA; Dy GK; Ou SI; Stephens PJ; McPherson JD; Lara PN; Burich RA; Ross JS; Miller VA; Ali SM; Mack PC; Schrock AB
J Thorac Oncol; 2018 Oct; 13(10):1560-1568. PubMed ID: 29981927
[TBL] [Abstract][Full Text] [Related]
33. Salivary gland cancer: ESMO-European Reference Network on Rare Adult Solid Cancers (EURACAN) Clinical Practice Guideline for diagnosis, treatment and follow-up.
van Herpen C; Vander Poorten V; Skalova A; Terhaard C; Maroldi R; van Engen A; Baujat B; Locati LD; Jensen AD; Smeele L; Hardillo J; Martineau VC; Trama A; Kinloch E; Even C; Machiels JP;
ESMO Open; 2022 Dec; 7(6):100602. PubMed ID: 36567082
[TBL] [Abstract][Full Text] [Related]
34. Comprehensive characterization of genes associated with the TP53 signal transduction pathway in various tumors.
Ohnami S; Ohshima K; Nagashima T; Urakami K; Shimoda Y; Saito J; Naruoka A; Hatakeyama K; Mochizuki T; Serizawa M; Ohnami S; Kusuhara M; Yamaguchi K
Mol Cell Biochem; 2017 Jul; 431(1-2):75-85. PubMed ID: 28258440
[TBL] [Abstract][Full Text] [Related]
35. Clinical and analytical validation of FoundationOne Liquid CDx, a novel 324-Gene cfDNA-based comprehensive genomic profiling assay for cancers of solid tumor origin.
Woodhouse R; Li M; Hughes J; Delfosse D; Skoletsky J; Ma P; Meng W; Dewal N; Milbury C; Clark T; Donahue A; Stover D; Kennedy M; Dacpano-Komansky J; Burns C; Vietz C; Alexander B; Hegde P; Dennis L
PLoS One; 2020; 15(9):e0237802. PubMed ID: 32976510
[TBL] [Abstract][Full Text] [Related]
36. Clinical impact of extensive molecular profiling in advanced cancer patients.
Cousin S; Grellety T; Toulmonde M; Auzanneau C; Khalifa E; Laizet Y; Tran K; Le Moulec S; Floquet A; Garbay D; Robert J; Hostein I; Soubeyran I; Italiano A
J Hematol Oncol; 2017 Feb; 10(1):45. PubMed ID: 28179005
[TBL] [Abstract][Full Text] [Related]
37. Automated quantitative tumour response assessment of MRI in neuro-oncology with artificial neural networks: a multicentre, retrospective study.
Kickingereder P; Isensee F; Tursunova I; Petersen J; Neuberger U; Bonekamp D; Brugnara G; Schell M; Kessler T; Foltyn M; Harting I; Sahm F; Prager M; Nowosielski M; Wick A; Nolden M; Radbruch A; Debus J; Schlemmer HP; Heiland S; Platten M; von Deimling A; van den Bent MJ; Gorlia T; Wick W; Bendszus M; Maier-Hein KH
Lancet Oncol; 2019 May; 20(5):728-740. PubMed ID: 30952559
[TBL] [Abstract][Full Text] [Related]
38. Feasibility of next-generation sequencing in clinical practice: results of a pilot study in the Department of Precision Medicine at the University of Campania 'Luigi Vanvitelli'.
De Falco V; Poliero L; Vitello PP; Ciardiello D; Vitale P; Zanaletti N; Giunta EF; Terminiello M; Caputo V; Carlino F; Di Liello R; Ventriglia A; Famiglietti V; Martinelli E; Morgillo F; Orditura M; De Vita F; Fasano M; Napolitano S; Martini G; Della Corte CM; Franco R; Altucci L; Ciardiello F; Troiani T
ESMO Open; 2020 Mar; 5(2):. PubMed ID: 32234730
[TBL] [Abstract][Full Text] [Related]
39. Sarcomas in patients over 90: Natural history and treatment-A nationwide study over 6 years.
Basse C; Italiano A; Penel N; Mir O; Chemin C; Toulmonde M; Duffaud F; Le Cesne A; Chevreau C; Maynou C; Anract P; Gouin F; Rios M; Firmin N; Kurtz JE; Kerbrat P; Piperno-Neumann S; Bertucci F; Rosset P; Isambert N; Bompas E; Dubray-Longeras P; Fiorenza F; Le Maignan C; Chaigneau L; Thyss A; Bouché O; Eymard JC; Delcambre Lair C; Adam J; Karanian M; Lebbé C; Dupré A; Meeus P; Brahmi M; Dufresne A; Ducimetière F; Ray-Coquard I; Blay JY
Int J Cancer; 2019 Oct; 145(8):2135-2143. PubMed ID: 30924137
[TBL] [Abstract][Full Text] [Related]
40. New insights in sarcoma oncogenesis: a comprehensive analysis of a large series of 160 soft tissue sarcomas with complex genomics.
Gibault L; Pérot G; Chibon F; Bonnin S; Lagarde P; Terrier P; Coindre JM; Aurias A
J Pathol; 2011 Jan; 223(1):64-71. PubMed ID: 21125665
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
